Overview
Providing antiretroviral therapy as a component of comprehensive HIV care is rapidly becoming a reality in many countries. Many questions remain, however, about the most effective, equitable, cost-effective, and balanced implementation of such programs. There are concerns about side effects of medications, the quality of life of patients, and the ability of patients to adhere to the regimen. Biomedical research will yield new and better drugs that are less toxic and easier to take. Clinical research will continue to improve and adapt drug combinations, taking into account viral resistance and side effects. Behavioral and social research will continue to explore possibilities for increased adherence and quality of life for patients, as well as increased social support and reduced stigma and discrimination.
The surveys below address many of the issues raised above, especially adherence, side effects, and symptoms. Questions related to
quality of life, social support, and
stigma and discrimination can be found in other topic sections of AIDSQuest.
Examples of questions relating to HIV treatment have been selected from the questionnaires below:
- Adherence
- Horizons—Adherence and Sexual Risk Behavior Among HIV-positive Patients Receiving Antiretroviral Therapy in Delhi and Pune, India
- Horizons—Testing Different Approaches to Promoting Adherence to HAART in Mombasa, Kenya (Baseline and endline)
- Horizons—Enhancing HAART in Thailand
-
Medical treatment, symptoms, and side effects
- Horizons—Adherence and Sexual Risk Behavior Among HIV-positive Patients Receiving Antiretroviral Therapy in Delhi and Pune, India
- Horizons—Testing Different Approaches to Promoting Adherence to HAART in Mombasa, Kenya (Baseline and endline)
- Horizons—Enhancing HAART in Thailand
